Camson Bio Technologies (BOM:538858) ROC %: -17.02% (As of Mar. 2019)


BOM:538858 Camson Bio Technologies Ltd BOM:538858
4 GF Score
Price ₹3.31
View Full Analysis

What is Camson Bio Technologies ROC %?

Camson Bio Technologies BOM:538858 4 ROC % is -17.02% as of Mar. 2019. GuruFocus rates BOM:538858 with a GF Score™ of 4/100.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Camson Bio Technologies's annualized return on capital (ROC %) for the quarter that ended in Mar. 2019 was -17.02%.

As of today (2026-07-06), Camson Bio Technologies's WACC % is 0.00%. Camson Bio Technologies's ROC % is 0.00% (calculated using TTM income statement data). Camson Bio Technologies earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Camson Bio Technologies  (BOM:538858) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Camson Bio Technologies's WACC % is 0.00%. Camson Bio Technologies's ROC % is 0.00% (calculated using TTM income statement data). Camson Bio Technologies earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Camson Bio Technologies ROC % Related Terms

Camson Bio Technologies ROC % Historical Data

* Premium members only.

The historical data trend for Camson Bio Technologies's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camson Bio Technologies ROC % Chart

Camson Bio Technologies Annual Data
Trend Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 -13.47 -11.13 -4.43 -17.02

Camson Bio Technologies Semi-Annual Data
Mar07 Mar08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 -13.47 -11.13 -4.43 -17.02
BOM:538858
4GF Score
Camson Bio Technologies Ltd BOM:538858
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Camson Bio Technologies ROC % Calculation

Camson Bio Technologies's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2019 is calculated as:

ROC % (A: Mar. 2019 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2018 ) + Invested Capital (A: Mar. 2019 ))/ count )
=-233.27 * ( 1 - 0% )/( (1408.604 + 1332.692)/ 2 )
=-233.27/1370.648
=-17.02 %

where

Invested Capital(A: Mar. 2018 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1415.437 - 169.366 - ( 0.906 - max(0, 631.354 - 468.821+0.906))
=1408.604

Invested Capital(A: Mar. 2019 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1221.053 - 178.492 - ( 0.636 - max(0, 639.719 - 349.588+0.636))
=1332.692

Camson Bio Technologies's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2019 is calculated as:

ROC % (Q: Mar. 2019 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2018 ) + Invested Capital (Q: Mar. 2019 ))/ count )
=-233.27 * ( 1 - 0% )/( (1408.604 + 1332.692)/ 2 )
=-233.27/1370.648
=-17.02 %

where

Invested Capital(Q: Mar. 2018 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1415.437 - 169.366 - ( 0.906 - max(0, 631.354 - 468.821+0.906))
=1408.604

Invested Capital(Q: Mar. 2019 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1221.053 - 178.492 - ( 0.636 - max(0, 639.719 - 349.588+0.636))
=1332.692

Note: The Operating Income data used here is one times the annual (Mar. 2019) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -17.02% mean?
Camson Bio Technologies (BOM:538858) has a ROC % of -17.02% as of Mar. 2019. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Camson Bio Technologies and its competitors.
Is Camson Bio Technologies' ROC % too high?
Camson Bio Technologies' current ROC % is -17.02%. Overall, Camson Bio Technologies has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Camson Bio Technologies' ROC % compare to CTVA and FMC?
Camson Bio Technologies' ROC % of -17.02% can be compared against companies in the Agriculture industry. The industry median ROC % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for an Agriculture company?
The median ROC % among Agriculture companies is 5.56, based on 255 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Camson Bio Technologies and its competitors. For the Agriculture industry, the median ROC % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Camson Bio Technologies's current ROC % is -17.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camson Bio Technologies stock overvalued right now?
Camson Bio Technologies (BOM:538858) has a current ROC % of -17.02%. The current ROC % is -17.02%. Camson Bio Technologies' overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Camson Bio Technologies (BOM:538858), the current ROC % is -17.02% as of Mar. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Camson Bio Technologies Business Description

Address Golden Enclave, Old Airport Road, C-7, 7th Floor, Corporate Block, Bangalore, KA, IND, 560017
Camson Bio Technologies Ltd is an agricultural biotechnology company. The firm is involved in the business of research, manufacturing and marketing of crop nutrition, bio-pesticide, natural fertilizers, bio fertilizers, bio-stimulants and hybrid seed varieties. The entire turnover of the company is from domestic business.
4GF Score

Get the complete analysis for BOM:538858

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.31
Price